Gene · 442906
MIR338: microRNA 338
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. MIR338: microRNA 338. Genes, record 442906. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/442906
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants463
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR338 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 2 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 2 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 2 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 2 | 2025 |
| ZIAAG000311 | ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease) | 2 | 2025 |
| I01BX001963 | Molecular Regulators of Mitochondria in Diabetic Cardiomyopathy | 1 | 2025 |
| I01BX004837 | Role of nitro-fatty acids in BBB stabilization and post-stroke neurovascular protection | 1 | 2025 |
1 to 10 of 463Source NIH's project files
See all 463 nih grantsPapers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTION: Bu Shen Yi Sui Capsules Promote Remyelination by Regulating MicroRNA-219 and MicroRNA-338 in Exosomes to Promote Oligodendrocyte Precursor Cell Differentiation. | Evid Based Complement Alternat Med | 2026 | 42311449 | PubTator, text mining | PubMed |
| Circular and Long Non-Coding RNAs in Cancer Metabolism: Dual Perspective of Biomarkers and Therapeutic Targets. | Noncoding RNA | 2026 | 41874139 | PubTator, text mining | PubMed |
| miR-214-3p exacerbates mitochondrial dysfunction in parkinson's disease: a multi-omics and mechanistic study. | Exp Brain Res | 2026 | 41793476 | PubTator, text mining | PubMed |
| The Ubiquitin Ligase Zinc Finger SWIM Domain-Containing Protein 8 Regulates Oligodendrocyte Development Through the Argonaute2/MicroRNA-7 Axis. | Glia | 2026 | 41787678 | PubTator, text mining | PubMed |
| JAK-STAT signaling: molecular mechanism and targeted treatment in dento-maxillofacial abnormalities. | Int J Oral Sci | 2026 | 41781377 | PubTator, text mining | PubMed |
| A systems approach to target discovery identifies the role of lncRNA-SPANXA2-OT1 in macrophage chemotaxis. | JCI Insight | 2025 | 41066194 | PubTator, text mining | PubMed |
| White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis. | Cells | 2025 | 41002375 | PubTator, text mining | PubMed |
| Circular RNA RORβ regulates TGFβR1 in alcohol-induced fibroblast-to-myofibroblast differentiation. | Sci Rep | 2025 | 40897735 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| Leveraging explainable multi-scale features for fine-grained circRNA-miRNA interaction prediction. | BMC Biol | 2025 | 40346538 | PubTator, text mining | PubMed |
1 to 10 of 1,644
See all 1,644 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/442906
GET https://conductscience.org/api/genes/v1/442906/grants?page=2